Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Үндсэн зохиолчид: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2006
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
-н: Mukhtyar, C, зэрэг
Хэвлэсэн: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
-н: Mukhtyar, C, зэрэг
Хэвлэсэн: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
-н: Saket Jha, зэрэг
Хэвлэсэн: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
-н: Zhi-Ying Li, зэрэг
Хэвлэсэн: (2020-08-01) -
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
-н: Moog P, зэрэг
Хэвлэсэн: (2015-11-01)